T1	Participants 91 134	patients with metastatic colorectal cancer.
T2	Participants 136 242	One hundred twenty-two chemotherapy-naive patients with histologically confirmed colorectal adenocarcinoma
T3	Participants 351 459	In both groups, patients received continuous infusion FU 1,000 mg/m2/d for 5 consecutive days every 4 weeks.
T4	Participants 1509 1553	patients with advanced colorectal carcinoma.
